Vascular Biology |
Requires Coactivation of Nuclear Factor-
B
From the Vascular Medicine Unit (T.B., U.L., V.L.F., P.L., J.K.L.), Brigham and Womens Hospital and Harvard Medical School, Boston, Mass; the CNR Institute of Clinical Physiology (R.D.C., G.L.), Pisa, and the Cardiovascular Division (R.D.C., G.L.), "G. DAnnunzio" University, Chieti, Italy; and the Department of Pathology (A.S.N.), Emory University Hospital, Atlanta, Ga.
Correspondence to James K. Liao, MD, Vascular Medicine and Atherosclerosis Unit, Brigham and Womens Hospital, 221 Longwood Ave, LMRC-322, Boston, MA 02115. E-mail jliao{at}rics.bwh.harvard.edu
AbstractTo
determine whether nuclear factor (NF)-
B is necessary to confer
endothelial cell responsiveness to interferon (INF)-
in terms of vascular cell adhesion molecule (VCAM)-1 expression and
leukocyte adhesion, human endothelial cells were
treated with IFN-
in the presence of low concentrations (LCs) of
interleukin (IL)-1
(
100 pg/mL), which activates NF-
B
but does not induce VCAM-1 expression. Although IFN-
induced major
histocompatibility complex class II antigen expression and although a
high concentration of IL-1
(10 ng/mL) induced leukocyte adhesion and
VCAM-1 expression, neither IFN-
nor LC IL-1
was able to induce
VCAM-1 expression or leukocyte adhesion. However, the combination of
IFN-
and LC IL-1
induced VCAM-1 expression and increased
leukocyte adhesion (67% and 49% of high-concentration IL-1
,
respectively). Electrophoretic mobility shift assays and
immunoblotting of nuclear extracts showed that IFN-
activated signal transducers and activators of
transcription (STAT)-1
and interferon regulatory factor (IRF)-1 but
not NF-
B, whereas LC IL-1
activated NF-
B but not
STAT-1
or IRF-1. Nuclear run-on studies showed that LC IL-1
is
necessary but not sufficient for inducing VCAM-1 gene transcription and
that the combination of IFN-
and LC IL-1
is required for full
VCAM-1 gene transcription. These findings suggest that factors that
activate NF-
B can synergize with IFN-
in promoting
endothelial-leukocyte interaction.
Key Words: endothelium adhesion molecules cytokines inflammation
This article has been cited by other articles:
![]() |
V. Fuster, P. R. Moreno, Z. A. Fayad, R. Corti, and J. J. Badimon Atherothrombosis and High-Risk Plaque: Part I: Evolving Concepts J. Am. Coll. Cardiol., September 20, 2005; 46(6): 937 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Dansky, P. Shu, M. Donavan, J. Montagno, D. L. Nagle, J. S. Smutko, N. Roy, S. Whiteing, J. Barrios, T. J. McBride, et al. A Phenotype-Sensitizing Apoe-Deficient Genetic Background Reveals Novel Atherosclerosis Predisposition Loci in the Mouse Genetics, April 1, 2002; 160(4): 1599 - 1608. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |